[go: up one dir, main page]

DE69927794D1 - Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten - Google Patents

Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten

Info

Publication number
DE69927794D1
DE69927794D1 DE69927794T DE69927794T DE69927794D1 DE 69927794 D1 DE69927794 D1 DE 69927794D1 DE 69927794 T DE69927794 T DE 69927794T DE 69927794 T DE69927794 T DE 69927794T DE 69927794 D1 DE69927794 D1 DE 69927794D1
Authority
DE
Germany
Prior art keywords
compositions
detection
diagnosis
mycobacterial diseases
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927794T
Other languages
English (en)
Other versions
DE69927794T2 (de
Inventor
Reiko M Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN BCG LAB TOKIO TOKYO
Original Assignee
JAPAN BCG LAB TOKIO TOKYO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN BCG LAB TOKIO TOKYO filed Critical JAPAN BCG LAB TOKIO TOKYO
Publication of DE69927794D1 publication Critical patent/DE69927794D1/de
Application granted granted Critical
Publication of DE69927794T2 publication Critical patent/DE69927794T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE69927794T 1998-02-06 1999-02-04 Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten Expired - Lifetime DE69927794T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7391198P 1998-02-06 1998-02-06
US73911P 1998-02-06
US9614098P 1998-08-11 1998-08-11
US96140P 1998-08-11
PCT/IB1999/000215 WO1999039693A2 (en) 1998-02-06 1999-02-04 Methods and compositions for detection and diagnosis of infectious diseases

Publications (2)

Publication Number Publication Date
DE69927794D1 true DE69927794D1 (de) 2006-03-02
DE69927794T2 DE69927794T2 (de) 2006-07-13

Family

ID=26755032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927794T Expired - Lifetime DE69927794T2 (de) 1998-02-06 1999-02-04 Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten

Country Status (9)

Country Link
US (3) US6979450B2 (de)
EP (1) EP1061905B1 (de)
JP (1) JP4323600B2 (de)
CN (3) CN1194670C (de)
AT (1) ATE306911T1 (de)
AU (1) AU4480899A (de)
CA (1) CA2319571C (de)
DE (1) DE69927794T2 (de)
WO (1) WO1999039693A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319571C (en) * 1998-02-06 2007-09-11 Japan Bcg Laboratory Methods and compositions for detection and diagnosis of infectious diseases
CN1656211B (zh) 2002-05-21 2010-04-28 爱科来株式会社 抗酸细菌的溶菌方法和用其进行基因扩增或检测的方法
WO2007130846A2 (en) * 2006-05-03 2007-11-15 Pritest, Inc. Improved compositions and methods of testing for tuberculosis and mycobacterium infection
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
CA2806062A1 (en) * 2010-07-19 2012-01-26 Arcion Therapeutics, Inc. Topical treatment of neuropathic pain and methods of diagnosis
ES2577011B1 (es) * 2015-01-09 2017-04-21 José Antonio FIZ FERNÁNDEZ Procedimiento para la lectura de la reacción de la tuberculina por toma de imágenes térmicas por infrarrojos
KR102192651B1 (ko) * 2017-08-23 2020-12-17 노을 주식회사 시약을 저장하는 저장 매체 및 이를 이용한 검사 방법 및 검사 모듈

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777130A (en) * 1984-12-05 1988-10-11 Andra Biologicals Isolation of mycobacterial a 60 antigen for diagnostic purposes
EP0199362A3 (de) * 1985-04-26 1987-10-07 Massachusetts Institute Of Technology System und Vorrichtung zur verzögerten und stossweisen Freisetzung biologisch aktiver Substanzen
JP2797308B2 (ja) 1988-03-25 1998-09-17 味の素株式会社 微生物セルロースの産生方法
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
JPH06169758A (ja) 1990-10-09 1994-06-21 Cosmo Sogo Kenkyusho:Kk 微生物及び５−アミノレブリン酸の製造方法
EP0612526A4 (de) * 1991-11-15 1995-08-02 Ss Pharmaceutical Co Entzündungshemmendes und analgetisches pflaster.
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
WO1996040236A1 (en) * 1995-06-07 1996-12-19 National Jewish Center For Immunology And Respiratory Medicine Isolated formylated bacterial peptides, nucleic acid molecules and uses thereof
JP3624389B2 (ja) 1996-01-30 2005-03-02 日本ビーシージー製造株式会社 Ｂｃｇ菌培養後の使用済み培養液より蛋白質を単離する方法
CA2319571C (en) * 1998-02-06 2007-09-11 Japan Bcg Laboratory Methods and compositions for detection and diagnosis of infectious diseases

Also Published As

Publication number Publication date
CN1292688A (zh) 2001-04-25
US7655218B2 (en) 2010-02-02
JP4323600B2 (ja) 2009-09-02
HK1035141A1 (en) 2001-11-16
HK1081437A1 (zh) 2006-05-19
CN1194670C (zh) 2005-03-30
CA2319571A1 (en) 1999-08-12
US20010043905A1 (en) 2001-11-22
WO1999039693A3 (en) 1999-09-23
US6979450B2 (en) 2005-12-27
CN1679928A (zh) 2005-10-12
WO1999039693A2 (en) 1999-08-12
AU4480899A (en) 1999-08-23
US20050106107A1 (en) 2005-05-19
EP1061905B1 (de) 2005-10-19
EP1061905A2 (de) 2000-12-27
ATE306911T1 (de) 2005-11-15
CN100584378C (zh) 2010-01-27
DE69927794T2 (de) 2006-07-13
CA2319571C (en) 2007-09-11
CN101804213A (zh) 2010-08-18
US20100278742A1 (en) 2010-11-04
JPH11263736A (ja) 1999-09-28

Similar Documents

Publication Publication Date Title
Friedman et al. Transmission of multidrug-resistant tuberculosis in a large urban setting.
ATE526994T1 (de) Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten
HUP0400719A2 (hu) Vegyületek és eljárások Chlamydia-fertőzés diagnosztikájára és kezelésére
TR200002938T2 (tr) Mikrobakteri tüberküloz antijenlerinin füzyon proteinleri ve bunların kullanımı
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
BR0009166A (pt) Vacina
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
HUP9900902A2 (hu) Vegyületek és eljárások a tuberkulózis diagnosztikájához és immunterápiájára
PT807178E (pt) Proteinas de micobacterias, microrganismos que as produzem e suas utilizacoes vacinicas e para a deteccao da tuberculose
PT854924E (pt) Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose
DE60023300D1 (de) Verwendung von cpg als adjuvans für hivimpstoff
FI895050A7 (fi) Diagnostisia valmisteita j rokotteita mykobakteereille kansanterveydel lisissä, lääketieteellisessä ja eläintieteellisessä toiminnassa
BR9814432A (pt) Composições derivadas de mycobacterium vaccae e processo para seu uso
DK0749582T3 (da) Fremgangsmåde til diagnosticering af præeklampsi
Cree et al. Leprosy transmission and mucosal immunity: towards eradication?
DE69927794D1 (de) Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten
WO2002054073A3 (en) Latent human tuberculosis model, diagnostic antigens, and methods of use
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
FR2677365B1 (fr) Proteines de mycobacterium et applications.
FI933291A0 (fi) Foerfarande foer paovisning av anti-rna-antikroppar
NO920331D0 (no) Biologisk preparat samt bruk derav
TR199501353A2 (tr) Allojenik ve ksenojenik proteinlere karsi antikorlar, bunlarin teshis ve tedavide kullanilmasi ve bunlarin saptanmasi icin yöntemler.
WO1999061909A3 (en) Methods and compositions for the detection of human herpesvirus
RU94007981A (ru) Штамм микобактерий mycobacterium avium гиск n 43, используемый для диагностики лепры
RU2001127052A (ru) Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition